drugset
drugset / Trial / NCT03317574

MEDITOXIN® in Treatment of Crow's Feet Line

NCT03317574 ↗

Phase 3 Completed 250 enrolled Medy-Tox
RandomizedParallel-groupQuadruple-blindTreatment

Summary

to determine the efficacy and safety of Meditoxin® in treatment of crow's feet line

Timeline

Start
2017-08-17
Primary completion
2017-12-01
Completion
2018-05-14

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin type A Protein / enzyme biologic 24 iu Other

Indications

No indication recorded.